𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies

✍ Scribed by C. Kasper

Publisher
Springer
Year
2001
Tongue
English
Weight
73 KB
Volume
80
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Erythropoietin for the treatment of anem
Erythropoietin for the treatment of anemia associated with hematological malignancy
✍ T. J. Littlewood πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

## Abstract Anemia is common in patients with hematological malignancy. Most patients will have their anemia attributed to the anemia of chronic disease. The anemia of chronic disease is caused by cytokine mediated suppression of erythropoiesis and low serum erythropoietin levels are found in the m

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ LeΓ³n, Pedro; JimΓ©nez, Miguel; Barona, Pascual; SierrasesΓΊmaga, Luis πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant